Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q3 2015 (← Previous) (Next →)

Filing Date: Nov 16, 2015

Total Value: $968M (97.8% shares, 2.2% debt)

Holdings (19)

VTI VANGUARD INDEX FDS 30.4%

Value $294M Shares 2,979,100 Est. Cost $57.39 Unrealized —

— OPHTHOTECH CORP 20.6%

Value $199M Shares 4,910,487 Est. Cost $32.35 Unrealized —

INGN INOGEN INC 17.8%

Value $172M Shares 3,549,320 Est. Cost $17.78 Unrealized +167.0%

VGK VANGUARD INTL EQUITY INDEX F 10.7%

Value $103M Shares 2,101,000 Est. Cost $45.01 Unrealized —

— NEVRO CORP 3.0%

Value $29.03M Shares 625,704 Est. Cost $38.67 Unrealized —

— TOBIRA THERAPEUTICS INC 2.7%

Value $26.05M Shares 2,696,405 Est. Cost $17.25 Unrealized —

— WRIGHT MEDICAL GROUP 2.2%

Value $20.89M Shares 4,622,032 Est. Cost $2.50 Unrealized —

ADAPY ADAPTIMMUNE THERAPEUTICS PLC 1.7%

Value $16.9M Shares 1,411,567 Est. Cost $18.33 Unrealized —

— OTONOMY INC 1.6%

Value $15.58M Shares 875,025 Est. Cost $24.00 Unrealized —

— FLEXION THERAPEUTICS INC 1.6%

Value $15.35M Shares 1,033,131 Est. Cost $17.27 Unrealized —

AKBA AKEBIA THERAPEUTICS INC 1.5%

Value $14.65M Shares 1,516,387 Est. Cost $24.08 Unrealized -61.9%

— TOKAI PHARMACEUTICALS INC 1.3%

Value $12.82M Shares 1,238,252 Est. Cost $14.41 Unrealized —

— COLUCID PHARMACEUTICALS INC 1.2%

Value $11.83M Shares 3,056,563 Est. Cost $8.90 Unrealized —

— INVUITY INC 1.1%

Value $11.04M Shares 787,282 Est. Cost $14.11 Unrealized —

— HTG MOLECULAR DIAGNOSTICS INC 1.0%

Value $9.755M Shares 1,280,185 Est. Cost $11.15 Unrealized —

— NABRIVA THERAPEUTICS AG 0.9%

Value $8.238M Shares 867,127 Est. Cost $9.50 Unrealized —

PEN PENUMBRA, INC. 0.4%

Value $4.208M Shares 104,944 Est. Cost $40.45 Unrealized 0.0%

GKOS GLAUKOS CORP 0.2%

Value $1.814M Shares 75,000 Est. Cost $29.05 Unrealized +3.6%

XENE XENON PHARMACEUTICALS INC 0.1%

Value $1.054M Shares 127,563 Est. Cost $14.68 Unrealized -32.4%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
VTI	VANGUARD INDEX FDS	2,979,100	$294M	30.4%	$57.39	—	TOTAL STK MKT	922908769
—	OPHTHOTECH CORP	4,910,487	$199M	20.6%	$32.35	—	COM	683745103
INGN	INOGEN INC	3,549,320	$172M	17.8%	$17.78	+167.0%	COM	45780L104
VGK	VANGUARD INTL EQUITY INDEX F	2,101,000	$103M	10.7%	$45.01	—	FTSE EUROPE ETF	922042874
—	NEVRO CORP	625,704	$29.03M	3.0%	$38.67	—	COM	64157F103
—	TOBIRA THERAPEUTICS INC	2,696,405	$26.05M	2.7%	$17.25	—	COM	88883P101
—	WRIGHT MEDICAL GROUP	4,622,032	$20.89M	2.2%	$2.50	—	CONTINGENT VALUE RIGHTS	98235T115
ADAPY	ADAPTIMMUNE THERAPEUTICS PLC	1,411,567	$16.9M	1.7%	$18.33	—	SPONDS ADR	00653A107
—	OTONOMY INC	875,025	$15.58M	1.6%	$24.00	—	COM	68906L105
—	FLEXION THERAPEUTICS INC	1,033,131	$15.35M	1.6%	$17.27	—	COM	33938J106
AKBA	AKEBIA THERAPEUTICS INC	1,516,387	$14.65M	1.5%	$24.08	-61.9%	COM	00972D105
—	TOKAI PHARMACEUTICALS INC	1,238,252	$12.82M	1.3%	$14.41	—	COM	88907J107
—	COLUCID PHARMACEUTICALS INC	3,056,563	$11.83M	1.2%	$8.90	—	COM	19716T101
—	INVUITY INC	787,282	$11.04M	1.1%	$14.11	—	COM	46187J106
—	HTG MOLECULAR DIAGNOSTICS INC	1,280,185	$9.755M	1.0%	$11.15	—	COM	40434H104
—	NABRIVA THERAPEUTICS AG	867,127	$8.238M	0.9%	$9.50	—	COM	62957M104
PEN	PENUMBRA, INC.	104,944	$4.208M	0.4%	$40.45	0.0%	COM	70975L107
GKOS	GLAUKOS CORP	75,000	$1.814M	0.2%	$29.05	+3.6%	COM	377322102
XENE	XENON PHARMACEUTICALS INC	127,563	$1.054M	0.1%	$14.68	-32.4%	COM	98420N105